CGH
BIVV

Crossmark Global Holdings’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Crossmark Global Holdings’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,939
Closed -$752K – 1652
2017
Q4 		$752K Sell
13,939
-3,498
-20% -$191K 0.02% 757
2017
Q3 		$995K Buy
+17,437
New +$1.02M 0.03% 611

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Crossmark Global Holdings's BIVV Position: Q1 2018 in Review

Crossmark Global Holdings sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,939 shares — an estimated $752K sold.

Crossmark Global Holdings first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $995K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Crossmark Global Holdings reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Crossmark Global Holdings sold 13,939 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $752K.
  • Crossmark Global Holdings first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Crossmark Global Holdings's Bioverativ Inc. Common Stock position peaked at $995K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Crossmark Global Holdings's 13F filing for Q1 2018, filed 16 Apr 2018.